Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001493152-24-011463

Options or other derivatives

  • CEO & President acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Equels Thomas K · CEO & President

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-11-30 Grant or award : show line 1 in the form Options +300,000 300,000 D
Loading xslF345X05/ownership.xml…